Nigerian drug makers are pushing on with investments and expansion but key challenges remain unresolved in the industry.
Even the acquisition of the World Health Organisation (WHO)’s prequalification has not helped some of them as expected, as exchange rate exposure and policy issues dog …...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.